Key facts
| Price (PPV) | 95.30 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | spiramycinemétronidazole |
| Class | Antibacterials for systemic use |
| ATC code | J01RA04 |
| Manufacturer | MAPHAR |
| Presentation | Boîte de 15 |
| Nature | Médicament |
| Hospital price | 59.60 MAD |
| Data collected on | 9/8/2026 |
Indications
L’association spiramycine-métronidazole est indiqué dans le traitement curatif d’infections odonto-stomatologiques tels que des abcès dentaires, chez l’adulte et chez l’enfant, après avoir évalué le rapport bénéfice-risque d’un traitement par cette association et lorsqu’un autre traitement antibiotique ne peut pas être utilisé. Il convient de tenir compte des recommandations officielles concernant l'utilisation appropriée des antibactériens.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 3 other products contain the same active substance as Bi-Rodogyl 1.5 MUI / 250 mg (Spiramycine | Métronidazole), at the same strength and in the same dosage form. For the same pack size (Boîte de 15), the cheapest is Bidontogyl 1.5 MUI / 250 mg (PHARMA5) at 70.50 MAD, i.e. 26 % less than Bi-Rodogyl 1.5 MUI / 250 mg (95.30 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Bidontogyl 1.5 MUI / 250 mg | PHARMA5 | Boîte de 15 | 70.50 MAD | 4.70 / unit | −26 % |
| Bispirazole 1.5 MUI / 250 mg | BOTTU S.A. | Boîte de 15 | 70.50 MAD | 4.70 / unit | −26 % |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Bi-Oragin 1.5 MUI / 250 mg | NOVOPHARMA | Blister 16 | 60.90 MAD | — |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Bi-Rodogyl 1.5 MUI / 250 mg
Bi-Rodogyl 1.5 MUI / 250 mg belongs to the antibacterials for systemic use therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Bi-Rodogyl 1.5 MUI / 250 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Bi-Rodogyl 1.5 MUI / 250 mg
Answers to common questions from Moroccan patients about this drug.